Inhibitory activity of vancomycin, eremomycin and teicoplanin aglycon derivatives against feline and human coronaviruses (i.e. SARS)

Jan Balzarini; Els Keyaerts; Leen Vijgen; De Clercq Erik; M. N. Preobrazhenskaya; Marc Van Ranst

Related publications

Article2005

Structure−Activity Relationship Studies of a Series of Antiviral and Antibacterial Aglycon Derivatives of the Glycopeptide Antibiotics Vancomycin, Eremomycin, and Dechloroeremomycin

Svetlana S. Printsevskaya, Svetlana E. Solovieva, Eugenia N. Olsufyeva, Elena P. Mirchink, Elena B. Isakova, De Clercq Erik, Jan Balzarini, M. N. Preobrazhenskaya

Article2005

Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture

Jan Balzarini, Els Keyaerts, Leen Vijgen, Frank Vandermeer, Miguel Stevens, De Clercq Erik, Herman Egberink, Marc Van Ranst

Article2010

Synthesis and Evaluation of Selected Key Methyl Ether Derivatives of Vancomycin Aglycon

Christine M. Crane, Joshua G. Pierce, Siegfried S. F. Leung, Julian Tirado‐Rives, William L. Jorgensen, Dale L. Boger

Journal of Medicinal Chemistry

Article2006

Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics

Jan Balzarini, Els Keyaerts, Leen Vijgen, Herman Egberink, De Clercq Erik, Marc Van Ranst, Svetlana S. Printsevskaya, Eugenia N. Olsufyeva, Svetlana E. Solovieva, M. N. Preobrazhenskaya

Article1994

<i>In vitro</i>Activity of Acyclic Nucleoside Phosphonate Derivatives against Feline Immunodeficiency Virus in Crandell Feline Kidney Cells and Feline Peripheral Blood Lymphocytes

Katrin Hartmann, Jan Balzarini, J. Higgins, De Clercq Erik, Niels C. Pedersen